{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T05:41:50Z","timestamp":1770529310022,"version":"3.49.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T00:00:00Z","timestamp":1521504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671186"],"award-info":[{"award-number":["81671186"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0194501","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T21:26:11Z","timestamp":1521581171000},"page":"e0194501","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and tolerability of short-term duloxetine treatment in adults with generalized anxiety disorder: A meta-analysis"],"prefix":"10.1371","volume":"13","author":[{"given":"Xinyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunkui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heqian","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7980-281X","authenticated-orcid":true,"given":"Shaokuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,3,20]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow","article-title":"Epidemiology of anxiety disorders in the 21st century","volume":"17","author":"B Bandelow","year":"2015","journal-title":"Dialogues Clin Neurosci"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archgenpsychiatry.2010.35","article-title":"High occurrence of mood and anxiety disorders among older adults: The National ComorbiditySurvey Replication","volume":"67","author":"AL Byers","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1017\/S1041610215000381","article-title":"Validation of the geriatric anxiety inventory in a duloxetine clinical trial for elderly adults with generalized anxiety disorder","volume":"27","author":"SG Ball","year":"2015","journal-title":"Int Psychogeriatr"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0022-3956(02)00005-5","article-title":"Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR","volume":"36","author":"SA Montgomery","year":"2002","journal-title":"J Psychiatr Res"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4088\/PCC.v09n0203","article-title":"Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians","volume":"9","author":"H Koponen","year":"2007","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jpsychires.2015.02.017","article-title":"Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: a systematic review and meta-analysis","volume":"64","author":"CU Pae","year":"2015","journal-title":"J Psychiatr Res"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/da.10141","article-title":"Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety inpatients with generalized anxiety disorder","volume":"19","author":"P Meoni","year":"2004","journal-title":"Depress Anxiety"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"M Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cpr.2017.03.006","article-title":"Generalized Anxiety Disorder, worry and attention to threat: A systematic review","volume":"54","author":"H Goodwin","year":"2017","journal-title":"Clin Psychol Rev"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.psychres.2008.02.011","article-title":"Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder","volume":"161","author":"GI Papakostas","year":"2008","journal-title":"Psychiatry Res"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2165\/00023210-200923060-00006","article-title":"Duloxetine: a review of its use in the treatment of generalized anxiety disorder","volume":"23","author":"NJ Carter","year":"2009","journal-title":"CNS Drugs"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/YIC.0b013e32807fb1b2","article-title":"Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial","volume":"22","author":"J Hartford","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/da.20271","article-title":"Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder:a flexible-dose,progressive-titration,placebo-controlled trial","volume":"25","author":"M Rynn","year":"2008","journal-title":"Depress Anxiety"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1017\/S0033291708003401","article-title":"Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial","volume":"39","author":"H Nicolini","year":"2009","journal-title":"Psychol Med"},{"issue":"20","key":"ref15","first-page":"3260","article-title":"Duloxetine versus placebo in the treatment of patients with generalized anxiety disorder in China","volume":"124","author":"WY Wu","year":"2011","journal-title":"Chin Med J (Engl)"},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/gps.4088","article-title":"Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial","volume":"29","author":"KJ Alaka","year":"2014","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"D Moher","year":"2009","journal-title":"BMJ"},{"issue":"Suppl 20","key":"ref18","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview(M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"DV Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"JP Higgins","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"e0175708","DOI":"10.1371\/journal.pone.0175708","article-title":"Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: a systematic review and meta-analysis","volume":"12","author":"Y Zhang","year":"2017","journal-title":"PLoS ONE"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"e0185865","DOI":"10.1371\/journal.pone.0185865","article-title":"Short-term efficacy and tolerability of venlafaxine extended release in adults with generalized anxiety disorder without depression: A meta-analysis","volume":"12","author":"X Li","year":"2017","journal-title":"PLoS ONE"},{"issue":"7109","key":"ref22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"e0176068","DOI":"10.1371\/journal.pone.0176068","article-title":"The relationship between diabetes and colorectal cancer prognosis: a meta-analysis based on the cohort studies","volume":"12","author":"B Zhu","year":"2017","journal-title":"PLoS ONE"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"e0166833","DOI":"10.1371\/journal.pone.0166833","article-title":"Efficacy and safety of anti-interleukin-5 therapy in patients with asthma: a systematic review and meta-analysis","volume":"11","author":"FP Wang","year":"2016","journal-title":"PLoS ONE"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1017\/S1092852915000553","article-title":"Treatment-emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: a pooled analysis","volume":"21","author":"PL Jacobsen","year":"2016","journal-title":"CNS Spectr"},{"key":"ref26","first-page":"23","article-title":"Duloxetine for the treatment of generalized anxiety disorder: a review","volume":"5","author":"AY Khan","year":"2009","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"d1199","DOI":"10.1136\/bmj.d1199","article-title":"Efficacy of drug treatment for generalized anxiety disorder: systematic review and meta-analysis","volume":"342","author":"D Baldwin","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40273-013-0031-z","article-title":"The cost effectiveness of pharmacological treatments for generalized anxiety disorder","volume":"31","author":"I Mavranezouli","year":"2013","journal-title":"Pharmacoeconomics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.2147\/NDT.S125367","article-title":"Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Y Okuyama","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"9","key":"ref30","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jclinepi.2005.01.006","article-title":"In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias","volume":"58","author":"N Terrin","year":"2005","journal-title":"J Clin Epidemiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0194501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T20:11:56Z","timestamp":1604002316000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0194501"}},"subtitle":[],"editor":[{"given":"Emilio","family":"Russo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,20]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0194501","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,20]]}}}